URAC Awards First Health Care Artificial Intelligence Accreditations
A new voluntary AI assurance mechanism for health care deployment illustrates how sector-specific third-party accreditation can complement internal model-risk and procurement governance.
Key points
- URAC awarded its first Health Care AI Accreditations to three US organisations in July–August 2026.
- The voluntary program covers AI governance, risk management, transparency, and monitoring across developer and user roles.
- Limited direct relevance to Australian federal agencies; useful as a sector-specific third-party assurance model to watch.
Implications for Australian agencies
- Monitor Agencies involved in health AI procurement or AI assurance framework development may want to monitor how sector-specific third-party accreditation models like URAC's evolve and whether analogous approaches emerge in Australia.
- Consider AI governance teams could consider whether the developer-versus-user distinction in URAC's framework offers a useful structuring concept for Australian agency AI procurement and vendor-review processes.
Implications are AI-generated. Starting points, not advice — see methodology for how they're framed.
View original source
Copied.
"URAC Awards First Health Care Artificial Intelligence Accreditations"
Source: Let's Data Science – AI Governance
Published: 5 August 2026
URL: https://letsdatascience.com/news/urac-awards-first-health-care-artificial-intelligence-accred-e56ca90b
URAC, a US health care accreditation body, has recognised Guidehealth, RediMinds, and SandsRx as the first recipients of its Health Care Artificial Intelligence Accreditation, launched in 2025. The voluntary program evaluates AI governance, transparency, risk management, bias management, data security, and ongoing operational oversight for both AI developers and organisations that deploy AI in clinical or operational workflows. Notably, the RediMinds evaluation prompted concrete enterprise controls including restrictions on employee use of public AI tools and expanded transparency disclosures. The awards establish a sector-specific third-party assurance benchmark, distinct from regulatory compliance or clinical effectiveness certification.
Implications for Australian agencies:
- [Monitor] Agencies involved in health AI procurement or AI assurance framework development may want to monitor how sector-specific third-party accreditation models like URAC's evolve and whether analogous approaches emerge in Australia.
- [Consider] AI governance teams could consider whether the developer-versus-user distinction in URAC's framework offers a useful structuring concept for Australian agency AI procurement and vendor-review processes.
Retrieved from SIMS, 16 September 2026.